Moon Pharmaceuticals is a early stage cannabinoid biotech focused on CB2/ECS research and product commercialization. Our simple mission is to end disease today.
We are extracting (ECS/CB2-specific agonists) cannabinoids from plants that are NOT cannabis or hemp to create formulations that have similar health benefits and effects. Because none of our products contain cannabis and therefore THC, our products can support your health in the same way as cannabis can, but without the psychoactive effects. Plus: 30 times less cost ($49.99 @100,000 mg of CB2 cannabinoids) compared to CBD/cannabis products like the FDA-approved Epidiolex ($2408.00 @100,000 mg of CB3 cannabinoids) and otc-legal worldwide today without needing a prescription.